Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19Derek C. Angus, Balasubramanian Venkatesh, Meredith Buxton et al.|JAMA|2020Cited by 884
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Patrick R. Lawler, Ewan C. Goligher et al.|Bristol Research (University of Bristol)|2021Cited by 589
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C. Angus, Steven Webb, Scott Berry et al.|Annals of the American Thoracic Society|2020Cited by 449
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyCarol Hodgson, Lauren O’Connor, Alisa M. Higgins et al.|Critical Care|2021Cited by 138
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportChristopher W. Seymour, Anthony Gordon, Paul Mouncey et al.|medRxiv|2021Cited by 137